Achieving optimal outcomes in chronic lymphocytic leukaemia.

Hamblin, T J

Hamblin, T J.

Affiliation

Hamblin TJ; Department of Haematology, Royal Bournemouth Hospital, England. terjoha@aol.com

Drugs ; 61(5): 593-611, 2001.

Article in En | MEDLINE | ID: mdl-11368285

Subject(s)

Antineoplastic Agents/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy; Aged; Antineoplastic Agents/adverse effects; Humans; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell/complications; Leukemia, Lymphocytic, Chronic, B-Cell/radiotherapy; Middle Aged; Prognosis; Randomized Controlled Trials as Topic

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols / Antineoplastic Agents Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Humans / Middle aged Language: En Journal: Drugs Year: 2001 Document type: Article Affiliation country: United kingdom Country of publication: New Zealand

Search on Google

Add to My VHL

XML

PubMed Links